Schedule 13D ownership disclosure
TRINITY BIOTECH INVT LTD
Class 'A' Ordinary Shares · CUSIP: 896438504
Event date: 2024-12-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mainstream Holdings, Ltd.
Shares: 0 · Class: 0%
- Mainstream New Growth No. 1 Private Equity Fund
Shares: 0 · Class: 0%
- New Main Equity Co., Ltd.Reported CIK 0002049455
Shares: 0 · Class: 0%
- Kim Chang-hee
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-24-140566
- Form type
- SCHEDULE 13D
- Filer
- New Main Equity Co., Ltd.
- CIK
- CIK 2049455
- Filed
- Dec 26, 2024
- Reporting period
- Dec 20, 2024
- Description
- Schedule 13D beneficial ownership